NEW YORK--(BUSINESS WIRE)--Neuro-Hitech, Inc. (NASDAQ: NHPI), a New York-based biopharmaceutical company focused on developing innovative drugs for the treatment of neurodegenerative diseases, announced today that it had received notice on March 17, 2008 from the NASDAQ Stock Market (“NASDAQ”) that for the previous 30 consecutive trading days, the Company’s common stock closed below the minimum $1.00 bid price per share required by Marketplace Rule 4310(c)(4).
